Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 2Zollinger-Ellison Syndrome 1Stomach Ulcer 1Inflammation 1Esophagitis, Peptic 1

Interventions

Omeprazole 2soybean oil, phospholipid emulsion 1salicylsalicylic acid 1ginger extract 1epigallocatechin gallate 1Vitamin D 1Sulindac 1Sodium Salicylate 1Riluzole 1Radiotherapy, Conformal 1Naproxen 1Febuxostat 1Etanercept 1Dexlansoprazole 1Colchicine 1ClinOleic 1Ascorbic Acid 1Art Therapy 1Allopurinol 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Inflammation × Dexlansoprazole × Clear all
NCT01093755 2016-03-17

Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

Mayo Clinic

Phase 4 Completed
30 enrolled 12 charts
Gastrointestinal

Barrett Esophagus, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡